Bangladesh Witnesses Alarming Increase in HIV Infections

Bangladesh maintains a low national HIV prevalence rate (below 0.1%) in the general population; however, the number of new cases has shown a worrying upward trend in recent years, particularly among specific high-risk or "key" populations. 

Key Statistics (as of late 2024 / October 2025 data):

• People Living with HIV (PLHIV) (Estimated): Approximately 16,863 to 17,480 people.
• New Cases Detected (Nov 2024–Oct 2025): 1,891 new infections, the highest annual rise since 2000. In the preceding year (2024 data), 1,438 cases were identified.
• AIDS-Related Deaths (2024 data): 195 deaths recorded.
• Cumulative Cases (as of end 2024): 12,422 registered cases.
• Overall National Prevalence (Adults 15-49): Below 0.1%. 

Key Affected Populations

The epidemic in Bangladesh is "concentrated," meaning the virus is more prevalent among specific groups rather than the general population. 

• People who inject drugs (PWID): Historically, this has been a major concern, with prevalence rates significantly higher in specific areas like Dhaka (e.g., 4.1% overall prevalence among KPs in 2020 data, peaking higher in specific neighborhoods).
• Men who have sex with men (MSM) and Transgender individuals (Hijra): HIV prevalence has increased significantly among MSM in recent years.
• Returning Migrants: A significant proportion of cases are detected among Bangladeshi migrant workers returning from abroad who contracted the virus while working in other countries.
• Rohingya Population: There is a notable number of cases within the Rohingya refugee population in Cox's Bazar. 

Challenges and Concerns

• Stigma and Discrimination: Fear of stigma prevents many high-risk individuals from seeking testing and treatment, making the epidemic harder to monitor and control.
• Awareness Gaps: Despite awareness campaigns, misconceptions about transmission and treatment persist among certain populations.
• Funding Cuts/Service Gaps: Insufficient funding and gaps in prevention and treatment services create a higher risk of the virus spreading further into the general population.
• Treatment Coverage: While the percentage of diagnosed individuals receiving Antiretroviral Therapy (ART) has improved, "lost to follow-up" cases (people who stop medication) remain a concern